Atypical revelation of atypical lung carcinoid; back pain after SARS-COV2 vaccination: A case report
1 Pulmonology department, Arrazi hospital, LRMS Lab, FMPM, Cadi Ayyad University, Marrakech, Morocco.
2 Pathology department, Arrazi hospital, LRMS Lab, FMPM, Cadi Ayyad University, Marrakech, Morocco.
Review Article
World Journal of Advanced Research and Reviews, 2023, 18(01), 863–869
Article DOI: 10.30574/wjarr.2023.18.1.0618
Publication history:
Received on 08 February 2023; revised on 13 April 2023; accepted on 15 April 2023
Abstract:
Background: Carcinoids make nearly 2% of all lung tumors, and the typical carcinoid are more frequent than atypical carcinoid (AC).
Case presentation: We report a histologically confirmed AC case of a 23-years old male patient; revealed by back chest pain as the first presentation; after a covid vaccination. Past medical history revealed that the patient had received the covid-19 vaccine in the days before the presentation. Contrast-enhanced computed tomography scan of the thorax revealed a tumor mass of the right fowler.
Conclusion: To our knowledge; this is the first case in literature. Whether bronchial carcinoid tumors are infrequent; they should be considered as differential diagnosis in patients even younger, with recurrent respiratory symptoms as timely and quick diagnosis is essential for curative intervention. We reported a first a COVID-19 vaccine- revealing symptoms of a bronchial atypical carcinoid, the characteristics that led to this phenomenon stay unclear, more studies are needed.
Keywords:
Atypical Carcinoid; Neuroendocrine Tumor; Lung Cancer; Case Report; Bronchoscopy; Covid
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0